SynthesisRMD open2025

Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.